A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 722
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : mGluR5
Long Form : metabotropic glutamate receptor 5
No. Year Title Co-occurring Abbreviation
2022 Artesunate Alleviates Paclitaxel-Induced Neuropathic Pain in Mice by Decreasing Metabotropic Glutamate Receptor 5 Activity and Neuroinflammation in Primary Sensory Neurons. DRG, MPEP, PINP
2022 Artesunate Reduces Remifentanil-induced Hyperalgesia and Peroxiredoxin-3 Hyperacetylation via Modulating Spinal Metabotropic Glutamate Receptor 5 in Rats. RIH
2022 Beyond monoamines: I. Novel targets and radiotracers for Positron emission tomography imaging in psychiatric disorders. PDE10A, PET
2022 Binding of a positive allosteric modulator CDPPB to metabotropic glutamate receptor type 5 (mGluR5) probed by all-atom molecular dynamics simulations. NAMs, PAMs
2022 Case Report: Guillain-Barré Syndrome Characterized by Severe Headache Associated With Metabotropic Glutamate Receptor 5 Antibody. CBA, CSF, GBS, HL, MRI
2022 Case report: Overlapping syndrome mimicking infectious meningoencephalitis in a patient with coexistent MOG, NMDAR, mGluR5 antibody positivity. CSF, MOG, MRI, NMDAR
2022 Characterization of a mGluR5 Knockout Rat Model with Hallmarks of Fragile X Syndrome. ASDs, ECM, FXS
2022 Cyclooxygenase-2 inhibition affects the expression of down syndrom cell adhesion molecule via interaction with metabotropic glutamate receptor 5. COX-2, DSCAM, HC, IgCAM, PFC
2022 Differences in mGluR5 Availability Depending on the Level of Social Avoidance in Drug-Naïve Young Patients with Major Depressive Disorder. BPND, H-SADS, L-SADS, MDD, MFC, PET, ROI, SADS, SFC
10  2022 Different Aberrant Changes of mGluR5 and Its Downstream Signaling Pathways in the Scrapie-Infected Cell Line and the Brains of Scrapie-Infected Experimental Rodents. Cyto-PrP, IFA
11  2022 Differential Role of mGluR5 in Cognitive Processes in Posttraumatic Stress Disorder and Major Depression. ATTN, HA, MDD, PET, PTSD
12  2022 Enhancing Endocannabinoid Signaling via β-Catenin in the Nucleus Accumbens Attenuates PTSD- and Depression-like Behavior of Male Rats. CB1R, FAAH, NAc
13  2022 Examining sex differences in responses to footshock stress and the role of the metabotropic glutamate receptor 5: an [18F]FPEB and positron emission tomography study in rats. BPND, FE, HR, LR, PET, PFC
14  2022 Fragile X Mental Retardation Protein and Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome: A Pilot Study. ASD, FM, FMRP, FXS, ID
15  2022 From bench to bedside: The mGluR5 system in people with and without Autism Spectrum Disorder and animal model systems. GABA, WT
16  2022 Glutamatergic transmission and receptor expression in the synucleinopathy h-α-synL62 mouse model: Effects of hydromethylthionine. alpha-Syn, DLB, HMTM, MTEP, NMDA, PD
17  2022 Human Metabotropic Glutamate Receptor 5 Antibodies Alter Receptor Levels and Behavior in Mice. IgG
18  2022 Interaction of JNK and mGluR5 in the regulation of psychomotor behaviours after repeated cocaine administration. CPu, CT, JNK
19  2022 Longitudinal PET studies of mGluR5 in FXS using an FMR1 knockout mouse model. BP, FMR1, FMR1-KO, FXS, PET
20  2022 Loss of schizophrenia-related miR-501-3p in mice impairs sociability and memory by enhancing mGluR5-mediated glutamatergic transmission. KO
21  2022 Metabotropic Glutamate Receptor 5 Antagonism Reduces Pathology and Differentially Improves Symptoms in Male and Female Heterozygous zQ175 Huntington's Mice. AD, HD
22  2022 Metabotropic glutamate receptor 5 blockade attenuates pathological cardiac remodelling in pulmonary arterial hypertension. Ang-2, CILP1, ELISA, IL-6, MCT, MTEP, P38 MAPK, PAH, PI3K, RSVP, SD, TNF-alpha, VEGF
23  2022 Metabotropic Glutamate Receptor 5 in Amygdala Target Neurons Regulates Susceptibility to Chronic Social Stress. BLA, mPFC, vHPC
24  2022 Metabotropic Glutamate Receptor 5 in the Dysgranular Zone of Primary Somatosensory Cortex Mediates Neuropathic Pain in Rats. SNL
25  2022 Metabotropic glutamate receptor 5 knockout rescues obesity phenotype in a mouse model of Huntington's disease. HD, VAT, WT
26  2022 Metabotropic glutamate receptor 5 upregulation of γ-aminobutyric acid transporter 3 expression ameliorates cognitive impairment after traumatic brain injury in mice. GABA, GAT3, TBI
27  2022 mGluR5 binding changes during a mismatch negativity task in a multimodal protocol with [11C]ABP688 PET/MR-EEG. BPND, MMN, PET
28  2022 mGluR5 PAMs rescue cortical and behavioural defects in a mouse model of CDKL5 deficiency disorder. CDKL5, CDPPB, CVI, PAMs
29  2022 Network pharmacology-based approach to investigate the mechanisms of Zingiber officinale Roscoe in the treatment of neurodegenerative diseases. AChE, COMT, GO, HMOX1, KEGG, NDDs, NOS
30  2022 Nitric Oxide Linked to mGluR5 Upregulates BDNF Synthesis by Activating MMP2 in the Caudate and Putamen after Challenge Exposure to Nicotine in Rats. BDNF, CPu, MMP, nNOS, NO
31  2022 Pannexin 1 role in the trigeminal ganglion in infraorbital nerve injury-induced mechanical allodynia. IONI, MHWT, Panx1, TG
32  2022 Phosphorylation of GluA1-Ser831 by CaMKII Activation in the Caudate and Putamen Is Required for Behavioral Sensitization After Challenge Nicotine in Rats. AMPA, CPu, D1R, IR, MSNs, NMDA, s.c, Ser831
33  2022 Reduced Metabotropic Glutamate Receptor Type 5 Availability in the Epileptogenic Hippocampus: An in vitro Study. MTLE, PET
34  2022 Repetitive transcranial magnetic stimulation regulates neuroinflammation, relieves hyperalgesia and reverses despair-like behaviour in chronic constriction injury rats. CCI, NMDAR2B, NP, rTMS, TNF-alpha
35  2022 Reversal of synapse loss in Alzheimer mouse models by targeting mGluR5 to prevent synaptic tagging by C1Q. AD, PET, SAM
36  2022 The mGlu5 Receptor Protomer-Mediated Dopamine D2 Receptor Trans-Inhibition Is Dependent on the Adenosine A2A Receptor Protomer: Implications for Parkinson's Disease. A2AR, D2R, D2R
37  2022 Transient astrocytic mGluR5 expression drives synaptic plasticity and subsequent chronic pain in mice. ---
38  2022 [Effects of trioxygen preconditioning on cerebral ischemia/reperfusion injury and glutamate receptor in rats]. AMPAR, I/R, NDS, Ozone group, SD, TTC
39  2021 A Novel Role of A2AR in the Maintenance of Intestinal Barrier Function of Enteric Glia from Hypoxia-Induced Injury by Combining with mGluR5. A2AR, EGCs, IEB, IR, KO
40  2021 Adenosine A2B receptor down-regulates metabotropic glutamate receptor 5 in astrocytes during postnatal development. ATP, DHPG
41  2021 An inpatient human laboratory study assessing the safety and tolerability, pharmacokinetics, and biobehavioral effect of GET 73 when co-administered with alcohol in individuals with alcohol use disorder. AD, AUD
42  2021 Behavioral and neurochemical profile of MK-801 adult zebrafish model: Forebrain β2-adrenoceptors contribute to social withdrawal and anxiety-like behavior. ASD, ATN, beta2-ARs, DAT, Dm, NMDA, SDM
43  2021 Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Idiopathic Autism Spectrum Disorder and Fragile X Syndrome: A Pilot Study. ASD, FXS, IASD, PET, TD
44  2021 Different roles of Numb-p72 and Numb-p65 on the trafficking of metabotropic glutamate receptor 5. ---
45  2021 Dynamic alterations in the central glutamatergic status following food and glucose intake: in vivo multimodal assessments in humans and animal models. MRS, PET
46  2021 Effect of age on brain metabotropic glutamate receptor subtype 5 measured with [18F]FPEB PET. ---
47  2021 Effects of two inhibitors of metabolic glutamate receptor 5 on expression of endogenous homer scaffold protein 1 in the auditory cortex of mice with tinnitus. MCPG, MPEP
48  2021 Emerging drugs for the prevention of migraine. CGRP, nNOSi, PACAP
49  2021 Evidence for the interaction of COX-2 with mGluR5 in the regulation of EAAT1 and EAAT3 protein levels in the mouse hippocampus. The influence of oxidative stress mechanisms. CNS, COX-2, EAAT, Glu, HC, LPS, MBM
50  2021 Functional Analysis of Brain Imaging Suggests Changes in the Availability of mGluR5 and Altered Connectivity in the Cerebral Cortex of Long-Term Abstaining Males with Alcohol Dependence: A Preliminary Study. BPND, PET, ROI, rs-fMRI
51  2021 Identification of Molecular Markers of Clozapine Action in Ketamine-Induced Cognitive Impairment: A GPCR Signaling PathwayFinder Study. CLZ, GalR2, GRK2, KET, mGluR1, PFC
52  2021 In vivo hippocampal cornu ammonis 1-3 glutamatergic abnormalities are associated with temporal lobe epilepsy surgery outcomes. BPND, CA, CI, FDG, MRI, MTLE, PET
53  2021 In vivo imaging of mGlu5 receptor expression in humans with Fragile X Syndrome towards development of a potential biomarker. FMRP, FXS
54  2021 Large-scale mGluR5 network abnormalities linked to epilepsy duration in focal cortical dysplasia. BPND, FCD
55  2021 Linking of NMDA receptors and mGluR5 in the nucleus accumbens core to repeated cocaine-induced 50-kHz ultrasonic vocalization in rats. NAc, NMDA, USV
56  2021 Loss of mGluR5 in D1 Receptor-Expressing Neurons Improves Stress Coping. cKO, FST, TWA
57  2021 Mavoglurant (AFQ056) for the treatment of levodopa-induced dyskinesia in patients with Parkinson's disease: a meta-analysis. LID, MD, PD
58  2021 Metabotropic Glutamate Receptor 5 in Natural Killer Cells Attenuates Liver Fibrosis by Exerting Cytotoxicity to Activated Stellate Cells. IFN-gamma, NK
59  2021 Metabotropic glutamate receptor 5 inhibits alpha-synuclein-induced microglia inflammation to protect from neurotoxicity in Parkinson's disease. PD
60  2021 mGluR5 Negative Modulators for Fragile X: Treatment Resistance and Persistence. FXS, GSK-3alpha, IA, NAMs
61  2021 mGluR5-Mediated eCB Signaling in the Nucleus Accumbens Controls Vulnerability to Depressive-Like Behaviors and Pain After Chronic Social Defeat Stress. 2-AG, CB1R, CHPG, CSDS, eCB, MDD, MTEP, NAc
62  2021 Mitochondrial biogenesis in developing astrocytes regulates astrocyte maturation and synapse formation. PPARgamma
63  2021 Negative Modulation of the Metabotropic Glutamate Receptor Type 5 as a Potential Therapeutic Strategy in Obesity and Binge-Like Eating Behavior. HFD, NAM
64  2021 Neonatal maternal separation affects metabotropic glutamate receptor 5 expression and anxiety-related behavior of adult rats. ---
65  2021 Noncanonical Metabotropic Glutamate Receptor 5 Signaling in Alzheimer's Disease. Abeta42, AD
66  2021 Quantification of Metabotropic Glutamate Receptor 5 Availability With Both [11C]ABP688 and [18F]FPEB Positron Emission Tomography in the Sapap3 Knockout Mouse Model for Obsessive-Compulsive-like Behavior. KO
67  2021 Reduced mGluR5 Activity Modulates Mitochondrial Function. ---
68  2021 Refractory Gastroesophageal Reflux Disease: A Management Update. GABA-B, GERD, H2RAs, LARS, PCABs, PPIs, rGERD, TIF
69  2021 Regional brain mGlu5 receptor occupancy following single oral doses of mavoglurant as measured by [11C]-ABP688 PET imaging in healthy volunteers. PET
70  2021 Sex differences in cocaine-associated memory: The interplay between CB1, mGluR5, and estradiol. CPP, EB, ER, MPEP, Rim
71  2021 Sex-specific behavioral impairments produced by neonatal exposure to MK-801 are partially reversed by adolescent CDPPB treatment. ---
72  2021 Sleep Disturbances Associated with Neurological Autoimmunity. AMPAR, ANNA-2, i.e., Ri, AQP4, CASPR2, GABA, LGI1, NMDA
73  2021 Specific changes in sleep oscillations after blocking human metabotropic glutamate receptor 5 in the absence of altered memory function. AMPA, NMDA, non-REM, REM
74  2021 Study of influence of the glutamatergic concentration of [18F]FPEB binding to metabotropic glutamate receptor subtype 5 with N-acetylcysteine challenge in rats and SRM/PET study in human healthy volunteers. NAC, PET
75  2021 The coming together of allosteric and phosphorylation mechanisms in the molecular integration of A2A heteroreceptor complexes in the dorsal and ventral striatal-pallidal GABA neurons. A2AR, FGFR1, STEP
76  2020 Activation of mGluR5 and NMDA Receptor Pathways in the Rostral Ventrolateral Medulla as a Central Mechanism for Methamphetamine-Induced Pressor Effect in Rats. Fos, i.c.v, MA, MAP, pGluN1-ser 896, PKC, RVLM
77  2020 Analysis of the Gut Microbiota and Inflammatory Factors in mGluR5-Knockout Mice. ELISAs, EPM, FST, OF, PFC, TST
78  2020 Association between human gray matter metabotropic glutamate receptor-5 availability in vivo and white matter properties: a [11C]ABP688 PET and diffusion tensor imaging study. BPND, DTI, FA, FDT, GM, PET, ROI, TBSS, WM
79  2020 Astrocyte Signaling Gates Long-Term Depression at Corticostriatal Synapses of the Direct Pathway. A1R, DLS, DREADDs, HFS, LTD
80  2020 Astroglial FMRP deficiency cell-autonomously up-regulates miR-128 and disrupts developmental astroglial mGluR5 signaling. FMRP, FXS
81  2020 Attenuation of Acute Intracerebral Hemorrhage-Induced Microglial Activation and Neuronal Death Mediated by the Blockade of Metabotropic Glutamate Receptor 5 In Vivo. ICH
82  2020 Behavioral consequences of co-administration of MTEP and the COX-2 inhibitor NS398 in mice. Part 2. COX-2, HC
83  2020 Bi-Directional Communication Between Neurons and Astrocytes Modulates Spinal Motor Circuits. CPG
84  2020 Blockade of metabotropic glutamate receptor 5 attenuates axonal degeneration in 6-hydroxydopamine-induced model of Parkinson's disease. MPEP, MTEP, p-ERK, PD
85  2020 Disabling phosphorylation at the homer ligand of the metabotropic glutamate receptor 5 alleviates complete Freund's adjuvant-induced inflammatory pain. ---
86  2020 Doublecortin and IGF-1R protein levels are reduced in spite of unchanged DNA methylation in the hippocampus of aged rats. DG, IGF-1R
87  2020 Downregulation of metabotropic glutamate receptor 5 alleviates central sensitization by activating autophagy via inhibiting mTOR pathway in a rat model of chronic migraine. CGRP, CM, IL-1beta, IS, LC3, SP, TNC
88  2020 Effects of blocking mGluR5 on primate dorsolateral prefrontal cortical neuronal firing and working memory performance. DLPFC
89  2020 Effects of sevoflurane anaesthesia on radioligand binding to monoamine oxidase-B invivo. MAO-B, NHPs, PET
90  2020 Electroacupuncture Regulates Pain Transition by Inhibiting the mGluR5-PKCε Signaling Pathway in the Dorsal Root Ganglia. DRG, EA, MWT, PGE2
91  2020 Endocannabinoid LTD in Accumbal D1 Neurons Mediates Reward-Seeking Behavior. 2-AG, eCB, LTD, MSNs, NAc
92  2020 Essential and sex-specific effects of mGluR5 in ventromedial hypothalamus regulating estrogen signaling and glucose balance. BDNF, VMH
93  2020 Excitatory amino acid transporter (EAAT)1 and EAAT2 mRNA levels are altered in the prefrontal cortex of subjects with schizophrenia. BA, EAAT, EAAT1, SKP1A, TFB1M
94  2020 In vivo glucose metabolism and glutamate levels in mGluR5 knockout mice: a multimodal neuroimaging study using [18F]FDG microPET and MRS. KO, MRS, NMDA, SUVs, WT
95  2020 Inhibiting MLL1-WDR5 interaction ameliorates neuropathic allodynia by attenuating histone H3 lysine 4 trimethylation-dependent spinal mGluR5 transcription. MLL1, SNL
96  2020 Isolation of rat hepatocytes for pharmacological studies on metabotropic glutamate receptor (mGluR) subtype 5: a comparison between collagenase I versus collagenase IV. IP-1, mGluR
97  2020 Metabotropic glutamate receptor 5 regulates synaptic plasticity in a chronic migraine rat model through the PKC/NR2B signal. cAMP, CM, pCREB-S133, pNR2B-Y1472, SYP, syt-1, tNR2B
98  2020 mGluR5 receptor availability is associated with lower levels of negative symptoms and better cognition in male patients with chronic schizophrenia. BPND
99  2020 mGluR5 regulates REST/NRSF signaling through N-cadherin/beta-catenin complex in Huntington's disease. HD, REST/NRSF
100  2020 Midbrain D3 Receptor Availability Predicts Escalation in Cocaine Self-administration. ---